Innovent Biologics Inc
HKEX:1801
Innovent Biologics Inc
HKEX:1801
Price:
85.4
HKD
7.56%
Market Closed
Market Cap:
HK$148.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innovent Biologics Inc
HKEX:1801
|
CN |
|
S
|
Sao Thang Long Investment JSC
VN:DST
|
VN |
|
V
|
VersaBank
TSX:VBNK
|
CA |
|
Capstone Companies Inc
OTC:CAPC
|
US |
|
J
|
Jiangsu NanFang Precision Co Ltd
SZSE:002553
|
CN |
|
A
|
Atlasclear Holdings Inc
AMEX:ATCH
|
US |
|
D
|
Dongzhu Ecological Environment Protection Co Ltd
SSE:603359
|
CN |
|
I-nexus Global PLC
LSE:INX
|
UK |
|
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
|
CN |
|
C
|
Crown Castle Inc
SWB:8CW
|
US |
|
W
|
Woori Technology Inc
KOSDAQ:032820
|
KR |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
CURO Group Holdings Corp
OTC:CUROQ
|
US |
|
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
CN |
|
Caica Digital Inc
TSE:2315
|
JP |
|
E
|
Energia Latina SA
SGO:ENLASA
|
CL |
|
ShenZhen Yitoa Intelligent Control Co Ltd
SZSE:300131
|
CN |
|
S
|
Shandong Taihe Water Treatment Technologies Co Ltd
SZSE:300801
|
CN |
|
A
|
Anhui Hyea Aromas Co Ltd
SZSE:300886
|
CN |
|
G
|
Geo-Jade Petroleum Corp
SSE:600759
|
CN |
|
B
|
Beijing Hengyu Datacom Aviation Equipment Co Ltd
SZSE:300965
|
CN |
|
Ferrovial SE
AEX:FER
|
NL |
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
Innovent Biologics Inc
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 85.4 HKD,
Innovent Biologics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Innovent Biologics Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Innovent Biologics Inc Competitors
Innovent Biologics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Innovent Biologics Inc
HKEX:1801
|
131.3B HKD | 10.8 | 109 | 60.2 | 81.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 34.9 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
